A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis

…, P Rutgeerts, J Schölmerich, LR Sutherland - …, 2007 - gastrojournal.org
Ulcerative colitis (UC) is a common gastrointestinal disorder in adults. Recent advances in
pathophysiology, immunology, and pharmaceutical science have resulted in a large number …

Azathioprine and 6-mercaptopurine in Crohn disease: a meta-analysis

…, GR May, GH Fick, LR Sutherland - Annals of internal …, 1995 - acpjournals.org
Purpose: To assess the effectiveness of azathioprine and 6-mercaptopurine in inducing
remission of active Crohn disease and the effectiveness of azathioprine in maintaining remission …

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

…, J Schölmerich, EF Stange, LR Sutherland - Gastroenterology, 2002 - Elsevier
Advances in immunology, biotechnology, and phar-maceutical science have resulted in an
unprecedented number of medications with potential application to the treatment of Crohn’s …

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998

…, WJ Sandborn, LR Sutherland - Inflammatory bowel …, 2000 - Wiley Online Library
Crohn's disease is a heterogeneous entity. Previous attempts of classification have been
based primarily on anatomic location and behavior of disease. However, no uniform definition …

5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis

LR Sutherland, F Martin, S Greer, M Robinson… - Gastroenterology, 1987 - Elsevier
The efficacy and safety of 4-g 5-aminosalicylic acid enemas were assessed in 153 patients
with ulcerative colitis involving up to 50 cm of distal colon. Seventy-six patients received …

[HTML][HTML] Oral budesonide for active Crohn's disease

…, BG Feagan, F Martin, LR Sutherland… - … England Journal of …, 1994 - Mass Medical Soc
Background Corticosteroids are the most efficacious drugs for inducing remission in active
Crohn's disease, but their benefits are frequently offset by serious side effects. Budesonide is …

Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease

AM Griffiths, A Ohlsson, PM Sherman, LR Sutherland - Gastroenterology, 1995 - Elsevier
… Griffiths, Sutherland, and Ohlsson using the criteria outlined by Chalmers et a1.14 (see …
Sutherland, and Ohlsson have training in clinical epidemiology and biostatistics; Drs. Sutherland

Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients

CJ Doig, LR Sutherland, J Dean Sandham… - American journal of …, 1998 - atsjournals.org
We conducted a prospective, observational cohort study designed to compare intestinal
permeability (IP) and development of multiple organ dysfunction syndrome (MODS) in a subset …

Oral 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis

LR Sutherland, JK MacDonald - Cochrane Database of …, 2006 - cochranelibrary.com
Oral 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis - Sutherland, LR
In an earlier meta‐analysis (Sutherland 1993), we found that the newer drugs were no more …

The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis

…, LJ Scully, UP Steinbrecher, LR Sutherland… - Hepatology, 1994 - journals.lww.com
Ursodeoxycholic acid, a dihydroxyl bile acid normally present in human beings in minimal
amounts, becomes incorporated into the bile salt pool when taken orally. In cholestasis, bile …